4.2 Article

Cortical and Hippocampal Atrophy in Patients with Autosomal Dominant Familial Alzheimer's Disease

Journal

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
Volume 32, Issue 2, Pages 118-125

Publisher

KARGER
DOI: 10.1159/000330471

Keywords

Familial Alzheimer's disease; Familial autosomal dominant Alzheimer's disease; Presenilin; Amyloid precursor protein; Hippocampal atrophy; Cortical atrophy; Mutation carriers

Funding

  1. Easton Consortium for Alzheimer Disease Drug Discovery and Biomarker Development
  2. NIA [K23 AG026803, P50 AG16570]
  3. NIBIB [EB008561, EB01651]
  4. NLM [LM05639]
  5. NCRR [RR019771]
  6. NIH [RR021813]
  7. PHS [K08 AG-22228, M01-RR00865]
  8. California DHS [04-35522]
  9. Goldberg Trust
  10. Sidell-Kagan Foundation
  11. [EB008281]
  12. [EB008432]
  13. [AG020098]
  14. [P41 RR013642]

Ask authors/readers for more resources

Background: Both familial and sporadic Alzheimer's disease (AD) result in progressive cortical and subcortical atrophy. Familial autosomal dominant AD (FAD) allows us to study AD brain changes presymptomatically. Methods: 33 subjects at risk for FAD (25 for PSEN1 and 8 for APP mutations; 22 mutation carriers and 11 controls) and 3 demented PSEN1 mutation carriers underwent T(1)-weighted MPRAGE 1.5T MRI. Using the hippocampal radial distance and cortical pattern matching techniques, we investigated the effects of carrier status and dementia diagnosis on cortical and hippocampal atrophy. All analyses were corrected for age and relative age (years to median age of disease onset in the family). Results: The dementia cases had pronounced cortical atrophy in the lateral and medial parietal, posterior cingulate and frontal cortices and hippocampal atrophy bilaterally relative to both nondemented carriers and controls. Nondemented carriers did not show significant cortical thinning or hippocampal atrophy relative to controls. Conclusions: FAD is associated with thinning of the posterior association and frontal cortices and hippocampal atrophy. Larger sample sizes may be necessary to reliably identify cortical atrophy in presymptomatic carriers. Copyright (C) 2011 S. Karger AG, Basel

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available